Oncoliq: Test for Early Breast Cancer Detection.

Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich

Status: Enrolling

Conditions: Breast Cancer

Treatments: Diagnostic Test: Oncoliq: test for early breast cancer detection.

Study type: Observational

Funder types: Other

Identifiers

NCT04906330

V1 11.12. 2020 (C.I.R.E.C.)

IS003208 (Registry Identifier)

Details and patient eligibility

About

Oncoliq is a novel early breast cancer detection test based on liquid biopsies and microRNAs. This innovative test will allow improving the accuracy of cancer detection which will impact on health, reducing the patient mortality and health costs.

To develop this test, it has been finished the preclinical PHASE I: in laboratory animals; PHASE II: exploratory clinical phase for the discovery of candidate biomarkers in breast cancer patients and PHASE III: clinical validation of biomarkers showing that Oncoliq has 91% of sensitivity.

Currently it is been setting up a "pilot test" for breast cancer to enrol 500 woman volunteers without previous cancer diagnosis that go to the annual medical control. The results of the pilot test will give the accuracy for early breast cancer detection.

Enrollment: 500 estimated patients

Sex: Female

Ages: 50 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women patients performing gynecological control
• Between 50-70 years old
• Without personal history of oncological disease
• Informed consent signed

Exclusion criteria

• Patients who don´t meet the inclusion criteria.
• Active infection with SARS-CoV-2 (COVID-19).

Trial design

500 participants in 1 patient group

PPHM-0000-21

Description:

50-70 year old female patients, without a personal history of oncological pathology, who attend for gynecological and mammographic control.

Treatment:

Diagnostic Test: Oncoliq: test for early breast cancer detection.